Total medical devices industry deals worth $8.1bn were announced globally for May 2021, with the $1.36bn acquisition of Vectura Group being the sector’s biggest investment, according to GlobalData’s deals database.
Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked an increase of 6.8% over the previous month of $7.56bn and a drop of 6.3% when compared with the last 12-month average of $8.61bn.
In terms of number of deals, the sector saw a drop of 10.30% with 148 deals in May 2021 when compared to the last 12-month average of 165 deals.
In value terms, North America led the activity with deals worth $4.61bn in May 2021.
Medical Devices industry deals in May 2021: Top deals
The top five deals accounted for 45.4% of the overall value during May 2021.
The combined value of the top five deals stood at $3.67bn, against the overall value of $8.1bn recorded for the month.
The top five medical devices industry deals of May 2021 tracked by GlobalData were:
1) Murano Bidco’s $1.36bn acquisition of Vectura Group
2) The $830m private equity deal with Caris Life Sciences by L.P, Canada Pension Plan Investment Board, ClearBridge Investments, Coatue Management, Columbia Threadneedle Investments, Eaton Vance, Fidelity Management & Research, First Light Asset Management, Highland Capital Management, Millennium Management, Orbimed Advisors, Pura Vida Investments, Rock Springs Capital Management, Silver Lake Management, T Rowe Price Associates, TPG Sixth Street Partners and Tudor Investment
3) Allergan Aesthetics’ $550m acquisition of Soliton
4) The $540m venture financing deal of Noom by Novo Holdings, Oak HC/FT Partners, RRE Ventures, Samsung Ventures Investment, Sequoia Capital Operations, Silver Lake Management and Temasek Holdings (Private)
5) NeoGenomics’ acquisition deal with Inivata for $390m.